X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-08 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.55 | -2,897 | 558,839 | -1% | -$13,181 | ||||||
2023-08-21 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.55 | -4,733 | 348,687 | -1% | -$16,811 | ||||||
2023-08-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.55 | -2,591 | 291,839 | -1% | -$9,203 | ||||||
2023-08-21 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $3.55 | -3,783 | 558,736 | -1% | -$13,436 | ||||||
2023-08-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.55 | -2,884 | 333,849 | -1% | -$10,243 | ||||||
2023-08-21 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.55 | -11,419 | 901,600 | -1% | -$40,558 | ||||||
2023-08-21 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.55 | -2,392 | 328,059 | -1% | -$8,496 | ||||||
2023-08-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.55 | -1,048 | 115,110 | -1% | -$3,722 | ||||||
2023-08-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.55 | -2,846 | 263,288 | -1% | -$10,108 | ||||||
2023-06-27 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.35 | -25,000 | 294,430 | -8% | -$83,633 | ||||||
| D | 2023-06-23 | ARDX | Blanks Robert | See Remarks | S - Sale+OE | $3.63 | -33,333 | 266,134 | -11% | -$121,042 | |||||
2023-05-23 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.65 | -1,046 | 116,158 | -1% | -$3,821 | ||||||
2023-05-23 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.65 | -11,357 | 913,019 | -1% | -$41,489 | ||||||
2023-05-23 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.65 | -2,384 | 330,451 | -1% | -$8,709 | ||||||
2023-05-23 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.65 | -2,835 | 266,134 | -1% | -$10,357 | ||||||
2023-05-23 | ARDX | Renz Justin A | CFO | S - Sale | $3.65 | -2,873 | 336,733 | -1% | -$10,496 | ||||||
2023-05-23 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.65 | -4,711 | 353,420 | -1% | -$17,210 | ||||||
2023-05-23 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $3.65 | -3,769 | 562,519 | -1% | -$13,769 | ||||||
2023-05-23 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.65 | -2,583 | 319,430 | -1% | -$9,436 | ||||||
2023-03-29 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.63 | -3,000 | 566,288 | -1% | -$13,888 | ||||||
2023-02-21 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.00 | -5,586 | 355,131 | -2% | -$16,764 | ||||||
2023-02-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.00 | -3,187 | 319,013 | -1% | -$9,564 | ||||||
2023-02-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.00 | -3,394 | 268,969 | -1% | -$10,185 | ||||||
2023-02-21 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.00 | -2,914 | 332,925 | -1% | -$8,745 | ||||||
2023-02-21 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.00 | -13,449 | 921,376 | -1% | -$40,360 | ||||||
2023-02-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.00 | -3,214 | 114,204 | -3% | -$9,645 | ||||||
2023-02-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.00 | -3,439 | 336,606 | -1% | -$10,320 | ||||||
2023-02-21 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $3.00 | -4,508 | 566,288 | -1% | -$13,529 | ||||||
2022-11-22 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $1.95 | -1,948 | 467,471 | 0% | -$3,797 | ||||||
2022-11-22 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $1.95 | -1,242 | 257,839 | 0% | -$2,421 | ||||||
2022-11-22 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $1.95 | -3,456 | 282,717 | -1% | -$6,736 | ||||||
2022-11-22 | ARDX | Raab Michael | Pres, CEO | S - Sale | $1.95 | -6,219 | 684,825 | -1% | -$12,120 | ||||||
2022-11-22 | ARDX | Renz Justin A | CFO | S - Sale | $1.95 | -1,504 | 262,045 | -1% | -$2,931 | ||||||
2022-11-22 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $1.95 | -1,241 | 244,200 | -1% | -$2,419 | ||||||
2022-11-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.95 | -1,464 | 194,363 | -1% | -$2,853 | ||||||
2022-11-17 | ARDX | Mott David M | Dir | P - Purchase | $1.76 | +567,000 | 1,166,765 | +95% | +$1,000,642 | ||||||
2022-10-05 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.50 | -100,000 | 195,827 | -34% | -$150,000 | ||||||
2022-08-31 | ARDX | Felsch Robert Ora | See Remarks | P - Purchase | $0.62 | +3,000 | 91,418 | +3% | +$1,856 | ||||||
2022-08-31 | ARDX | Rosenbaum David P. | Chief Development Officer | P - Purchase | $0.62 | +3,000 | 469,419 | +1% | +$1,856 | ||||||
2022-09-01 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.92 | -3,000 | 469,419 | -1% | -$2,760 | ||||||
2022-08-31 | ARDX | Renz Justin A | CFO | P - Purchase | $0.62 | +3,000 | 263,549 | +1% | +$1,856 | ||||||
2022-08-31 | ARDX | Williams Laura A | Chief Medical Officer | P - Purchase | $0.62 | +3,000 | 245,441 | +1% | +$1,856 | ||||||
2022-08-31 | ARDX | Raab Michael | Pres, CEO | P - Purchase | $0.62 | +3,000 | 691,044 | 0% | +$1,856 | ||||||
2022-08-31 | ARDX | Grammer Elizabeth A | See Remarks | P - Purchase | $0.62 | +3,000 | 259,081 | +1% | +$1,856 | ||||||
2022-08-26 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.04 | -21,842 | 295,827 | -7% | -$22,713 | ||||||
2022-08-22 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $0.98 | -3,420 | 286,173 | -1% | -$3,364 | ||||||
2022-08-22 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.98 | -1,955 | 469,419 | 0% | -$1,923 | ||||||
2022-08-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.98 | -1,458 | 317,669 | 0% | -$1,434 | ||||||
2022-08-22 | ARDX | Raab Michael | Pres, CEO | S - Sale | $0.98 | -6,146 | 688,044 | -1% | -$6,045 | ||||||
2022-08-22 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $0.98 | -1,236 | 256,081 | 0% | -$1,216 | ||||||
2022-08-22 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $0.98 | -1,276 | 242,441 | -1% | -$1,255 | ||||||
2022-08-22 | ARDX | Renz Justin A | CFO | S - Sale | $0.98 | -1,498 | 260,549 | -1% | -$1,474 | ||||||
2022-07-26 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.67 | -5,188 | 319,127 | -2% | -$3,476 | ||||||
2022-06-06 | ARDX | Renz Justin A | CFO | S - Sale | $0.65 | -73,312 | 262,047 | -22% | -$47,696 | ||||||
2022-06-06 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $0.65 | -43,920 | 289,593 | -13% | -$28,574 | ||||||
2022-06-06 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.65 | -73,312 | 324,315 | -18% | -$47,696 | ||||||
2022-06-06 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $0.65 | -60,821 | 257,317 | -19% | -$39,569 | ||||||
2022-06-06 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.65 | -61,640 | 471,374 | -12% | -$40,102 | ||||||
2022-06-06 | ARDX | Raab Michael | Pres, CEO | S - Sale | $0.65 | -103,624 | 694,190 | -13% | -$67,416 | ||||||
2022-05-20 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.67 | -2,013 | 533,014 | 0% | -$1,352 | ||||||
2022-05-20 | ARDX | Renz Justin A | CFO | S - Sale | $0.67 | -1,528 | 335,359 | 0% | -$1,026 | ||||||
2022-05-20 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $0.67 | -3,425 | 333,513 | -1% | -$2,300 | ||||||
2022-05-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.67 | -1,489 | 397,627 | 0% | -$1,000 | ||||||
2022-05-20 | ARDX | Raab Michael | Pres, CEO | S - Sale | $0.67 | -6,124 | 797,814 | -1% | -$4,112 | ||||||
2022-05-20 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $0.67 | -1,263 | 318,138 | 0% | -$848 | ||||||
2022-02-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.67 | -1,752 | 399,116 | 0% | -$1,174 | ||||||
2022-02-22 | ARDX | Raab Michael | Pres, CEO | S - Sale | $0.67 | -6,229 | 800,938 | -1% | -$4,173 | ||||||
2022-02-22 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.67 | -2,353 | 532,027 | 0% | -$1,577 | ||||||
2022-02-22 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $0.67 | -3,400 | 333,938 | -1% | -$2,278 | ||||||
| M | 2021-12-09 | ARDX | Sandell Scott D | 10% | S - Sale | $1.26 | -2,881,570 | 10,752,106 | -21% | -$3,642,572 | |||||
| M | 2021-12-09 | ARDX | Baskett Forest | 10% | S - Sale | $1.26 | -2,881,570 | 10,752,012 | -21% | -$3,642,572 | |||||
2021-11-22 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $0.99 | -827 | 479,380 | 0% | -$820 | ||||||
2021-11-22 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $0.99 | -643 | 197,030 | 0% | -$638 | ||||||
2021-11-22 | ARDX | Renz Justin A | CFO | S - Sale | $0.99 | -643 | 293,687 | 0% | -$638 | ||||||
2021-11-22 | ARDX | Raab Michael | Pres, CEO | S - Sale | $0.99 | -2,607 | 657,167 | 0% | -$2,586 | ||||||
2021-11-22 | ARDX | Jacobs Jeffrey W | Chief Scientific Officer | S - Sale | $0.98 | -5,754 | 119,483 | -5% | -$5,629 | ||||||
2021-11-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.99 | -643 | 360,868 | 0% | -$638 | ||||||
2021-11-22 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $0.99 | -537 | 278,929 | 0% | -$533 | ||||||
2021-11-15 | ARDX | Jacobs Jeffrey W | Chief Scientific Officer | S - Sale | $1.13 | -5,000 | 125,237 | -4% | -$5,650 | ||||||
2021-11-12 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $1.13 | -77,432 | 279,466 | -22% | -$87,111 | ||||||
2021-11-08 | ARDX | Jacobs Jeffrey W | Chief Scientific Officer | S - Sale | $1.18 | -2,166 | 130,237 | -2% | -$2,556 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |